Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Brain Surgery
Intracranial arterial angioplasty and stenting
Intracranial arterial angioplasty and stenting is an endovascular procedure used to widen narrowed brain arteries in patients with severe intracranial atherosclerosis and recurrent ischemic symptoms. This guide explains how angioplasty balloons and stents restore cerebral blood flow, clinical evidence regarding stroke prevention, candidate criteria, hospital costs in Turkey compared with other countries, recovery timelines, procedural risks and clinic standards.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Brain Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Intracranial Arterial Angioplasty and Stenting
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Intracranial arterial angioplasty and stenting: what it is and how it works
Intracranial arterial angioplasty and stenting is an endovascular surgical procedure designed to widen severely narrowed arteries inside the brain and restore cerebral blood circulation. Atherosclerosis can cause fatty plaques to accumulate inside major intracranial vessels, including the internal carotid, middle cerebral, vertebral and basilar arteries. This condition, known as intracranial atherosclerotic disease, restricts blood supply to brain tissue and represents a primary cause of recurrent transient ischemic attacks and ischemic stroke.
The intervention accesses the arterial system through a puncture in the groin or wrist. Working under continuous fluoroscopic guidance, a neurointerventional specialist navigates microcatheters up into the skull. A deflated balloon catheter is positioned across the stenosis and inflated to dilate the lumen. A specialized intracranial stent is then deployed to scaffold the vessel wall and maintain long-term patency. For an overview of surgical and endovascular brain care, consult our guide to neurosurgery treatments in Turkey.
Does intracranial arterial angioplasty and stenting work?
Clinical studies demonstrate that intracranial stenting reliably restores arterial lumen diameter, significantly reducing mechanical stenosis on catheter angiography. However, scientific evidence regarding stroke prevention shows that clinical success depends entirely on patient selection. Major clinical trials, including the SAMMPRIS and VISSIT trials, demonstrated that routine stenting for newly diagnosed intracranial stenosis carried a higher immediate risk of periprocedural stroke or haemorrhage compared with aggressive medical therapy consisting of dual antiplatelet medication, high-intensity statins and strict blood pressure control.
Subsequent registries such as the WEAVE study established that when intracranial arterial angioplasty and stenting is reserved for carefully selected patients who experience recurrent ischemic symptoms despite maximal medical therapy, procedural safety improves substantially in high-volume centres. The procedure does not regenerate brain tissue damaged by previous strokes, nor does it eliminate future vascular risks. It functions specifically as a mechanical revascularisation option to prevent recurrent hypoperfusion in patients who have failed medical management.
Who is an appropriate candidate for intracranial stenting?
Determining candidate suitability requires thorough multidisciplinary assessment by neurologists and neurointerventional surgeons. Appropriate candidates generally meet specific criteria:
- Angiographically confirmed severe intracranial stenosis, typically narrowing 70% to 99% of the arterial diameter.
- Recurrent transient ischemic attacks or non-disabling strokes directly attributable to the narrowed arterial territory.
- Failure of aggressive medical management, defined as symptom recurrence while taking therapeutic dual antiplatelet medication and statins.
- Sufficient functional independence, allowing the patient to tolerate the intervention and subsequent rehabilitation.
- Vascular anatomy that permits safe microcatheter navigation without extreme vessel tortuosity.
Conversely, individuals who are not suitable candidates include those with asymptomatic arterial narrowing, mild-to-moderate stenosis (under 70%), acute completed major ischemic stroke with extensive infarction, active intracranial haemorrhage, severe coagulopathy or intolerance to long-term antiplatelet agents. Treating asymptomatic narrowing with intracranial stents carries procedural hazards that outweigh the natural disease risk.
How intracranial arterial angioplasty and stenting is performed step by step
The procedure takes place in a biplane neuroangiography suite and requires between 90 minutes and three hours depending on vascular complexity. Before treatment, patients undergo premedication with dual antiplatelet agents to minimise acute thromboembolic complications.
The intervention proceeds through four defined stages:
- Anaesthesia and arterial access: The procedure is usually performed under general anaesthesia to ensure immobility. The specialist punctures the femoral artery in the groin or the radial artery in the wrist and inserts an introducer sheath.
- Catheter navigation and angiography: A guide catheter is positioned in the cervical carotid or vertebral artery. Under high-resolution digital subtraction angiography, the operator advances an ultra-fine microguidewire and microcatheter across the stenotic lesion.
- Balloon angioplasty and stent deployment: A sub-maximal balloon catheter is advanced across the narrowing and inflated to pre-dilate the vessel. An intracranial stent is deployed across the lesion to secure the lumen. In some cases, balloon-mounted stents perform both steps simultaneously.
- Post-procedural imaging and closure: Final angiograms verify restored arterial diameter, normal cerebral perfusion and absence of emboli or dissection. Catheters are removed and the access site is sealed with a vascular closure device.
Intracranial arterial angioplasty and stenting cost in Turkey and abroad
The figures below outline approximate international cost ranges for intracranial angioplasty and stenting. These ranges represent general commercial estimates rather than hospital-specific quotes, as pricing varies with device selection, intensive care duration and clinical complexity.
| Country | Approximate cost range |
|---|---|
| Turkey | €9,500 – €22,000 |
| United Kingdom | €18,000 – €35,000 |
| United States | €35,000 – €85,000 |
| Germany | €16,000 – €32,000 |
Several factors determine the final price. Precision intracranial microstents and microcatheters represent high-cost medical hardware. The requirement for general anaesthesia, neuro-monitoring technology, biplane angiography facilities and mandatory care in a dedicated neuro-intensive care unit (NICU) also affects total expenditure. In Turkey, medical travel packages generally bundle pre-procedural neuroimaging, the endovascular intervention, stent devices, 24 to 48 hours of NICU monitoring, hospital ward accommodation, post-operative medications, translator support and airport transfers. Patients should obtain an itemised clinical quote specifying included devices and intensive care nights before travelling.
Intracranial stenting compared with medical management and bypass surgery
Specialists evaluate endovascular intervention alongside medical therapy and open revascularisation surgery when formulating a treatment strategy. Each approach addresses arterial narrowing through different mechanisms.
| Treatment approach | Best suited to | Typical limits |
|---|---|---|
| Intracranial stenting and angioplasty | Severe symptomatic stenosis (>70%) failing dual antiplatelet therapy | Higher immediate periprocedural risk; requires long-term antiplatelets |
| Aggressive medical management | Initial diagnosis of intracranial stenosis or moderate narrowing (<70%) | May not prevent recurrent ischemic events in haemodynamically unstable lesions |
| Extracranial-intracranial (EC-IC) bypass | Selected vascular occlusions or severe hypoperfusion unsuitable for catheter access | Open craniotomy with prolonged surgical recovery and specific anatomical limits |
Aggressive medical management remains the first-line treatment for almost all individuals diagnosed with intracranial stenosis because it avoids acute procedural hazards. Surgical bypass involves a craniotomy to connect an external scalp artery to a cortical brain artery; while valuable in specific occlusive diseases, it carries the substantial physical impact of open neurosurgery. While cerebrovascular procedures focus on arterial lumen restoration, skull-base and oncology cases involve different surgical pathways, such as transnasal resection of tumor.
Angiographic outcomes: what before and after scans show
Because intracranial stenting is an endovascular operation, outcomes are evaluated primarily through objective neuroimaging rather than external appearance. Pre-procedural catheter angiography or CT angiography typically demonstrates a high-grade focal narrowing, showing marked reduction of vessel caliber where contrast passage is visibly delayed.
Post-procedural scans show immediate mechanical widening of the vessel lumen, with the metallic stent scaffolding the arterial wall and establishing smooth, unobstructed blood flow into distal cerebral territories. Clinically, successful revascularisation prevents recurrent transient ischemic episodes and ischemic strokes. However, patients and caregivers must understand that stenting does not reverse established neurologic deficits caused by prior strokes, such as existing muscle weakness or speech difficulty. Follow-up imaging with magnetic resonance angiography (MRA) or transcranial Doppler ultrasound is scheduled at three, six and twelve months to verify long-term vessel patency and monitor for in-stent restenosis.
Hospital stay and recovery after intracranial arterial angioplasty and stenting
Recovery begins with mandatory monitoring in a neuro-intensive care unit for the first 24 to 48 hours. Medical teams monitor blood pressure continuously using arterial lines, maintaining strict targets to prevent hyperperfusion syndrome—a complication where sudden normalisation of blood pressure into chronically underperfused vessels causes tissue edema or haemorrhage. Neurological examinations are conducted hourly to assess cognitive status, limb movement and speech.
Patients remain on bed rest for several hours after sheath removal to ensure stable arterial closure. Once transferred to a regular room, gentle mobilisation begins under clinical supervision. Total hospitalisation usually lasts three to five days. International patients generally stay in Turkey for seven to ten days to complete post-operative reviews, blood pressure stabilization and travel clearance before flying home. Dual antiplatelet medication must be continued without interruption for three to six months, followed by lifelong single antiplatelet therapy. Strenuous exertion should be avoided for four to six weeks, while light daily activities can resume after two weeks.
Risks, safety considerations and complications
Intracranial arterial angioplasty and stenting is a complex endovascular intervention involving delicate cerebral vasculature, and it carries significant clinical risks. Clinical guidelines from the American Heart Association (AHA) and the European Stroke Organisation (ESO) emphasise that this procedure should only be performed when aggressive medical therapy has failed.
Documented procedural risks and complications include:
- Periprocedural ischemic stroke: Caused by dislodged micro-emboli during catheter manipulation or plaque displacement occluding small perforating brain arteries.
- Intracranial haemorrhage: Resulting from vessel rupture during balloon dilation, microguidewire vessel perforation or cerebral hyperperfusion injury.
- Arterial dissection: Tearing of the delicate inner arterial lining during catheter or wire advancement.
- In-stent restenosis: Gradual re-narrowing of the stent lumen over months due to cellular proliferation within the vascular wall.
- Access-site complications: Groin or wrist haematoma, retroperitoneal bleeding, pseudoaneurysm formation or femoral artery occlusion.
- Contrast-induced nephropathy or allergic reactions: Adverse reactions to radiographic contrast material, requiring hydration management.
How to evaluate a neurointerventional centre and red flags
Selecting an appropriate hospital for intracranial stenting requires verifying clinical infrastructure, interventional volume and emergency neurosurgical support. Patients considering treatment abroad should seek hospitals equipped with modern biplane digital subtraction angiography suites, round-the-clock neuro-intensive care units staffed by dedicated neuro-intensivists, and endovascular neurosurgeons or interventional neuroradiologists who perform high annual volumes of cerebral interventions. To understand how hospital coordination, preliminary imaging reviews and travel planning operate, review how it works.
You can submit your brain angiograms and neurology reports through our free quote form to receive itemised clinical proposals. Patients evaluating complex neurological hospital care can also browse the wider spectrum of neurosurgery treatments in Turkey to assess hospital capability.
Red flags include clinics that recommend intracranial stenting for asymptomatic stenosis, facilities lacking an on-site neuro-ICU or emergency craniotomy capabilities, providers offering treatment without reviewing prior catheter angiography or MRI/MRA images, and medical coordinators who claim the operation is routine or without serious risks.
Essential questions to ask your neurointerventional team
Before committing to treatment, discuss the following critical questions with your treating specialist:
- Has my medical management with dual antiplatelet therapy and statins been fully optimised?
- What exact degree of stenosis is present, and in which intracranial vessel?
- How many intracranial angioplasty and stenting procedures does your team perform annually?
- What is your centre's specific periprocedural complication rate for this procedure?
- What type of stent do you recommend for my anatomy, and why?
- How long will I be monitored in the neuro-intensive care unit?
- What antiplatelet medication regimen will I need to follow after discharge?
- What emergency protocols are in place if an arterial complication occurs?
- How will my follow-up imaging checks be coordinated once I return home?
Before committing to overseas travel, submit your diagnostic catheterisation runs for a second evaluation and request a free quote.
Hospitals with Neurosurgery in Turkey
Frequently asked questions
Intracranial arterial angioplasty and stenting is an endovascular procedure used to widen narrowed arteries inside the brain caused by atherosclerotic plaque buildup. A specialist navigates a microcatheter through the vascular system, dilates the narrowed arterial segment with a tiny balloon, and deploys a permanent mesh stent to keep the vessel open and restore cerebral blood flow.
It effectively restores vessel lumen diameter and cerebral perfusion. However, large clinical trials show that upfront stenting carries higher immediate risks than medical therapy alone. Stenting is primarily indicated for carefully selected patients with severe stenosis greater than 70% who continue to experience recurrent ischemic strokes or transient ischemic attacks despite taking maximal dual antiplatelet medications.
In Turkey, intracranial arterial angioplasty and stenting typically costs between €9,500 and €22,000, compared with €18,000 to €35,000 in the UK and higher in the US. The price depends on the specific stent and catheter devices required, duration of neuro-intensive care monitoring, pre-operative angiography and hospital stay length. Clinics confirm exact pricing following imaging review.
Pre-procedure catheter angiograms or CT angiograms reveal severe arterial narrowing where cerebral blood flow is visibly restricted. Post-procedure scans show immediate restoration of normal arterial caliber, with the stent holding the vessel open and blood flowing freely into distal brain vessels. Stenting prevents future ischemic events but cannot reverse permanent tissue damage from prior strokes.
Patients typically spend one to two days in a neuro-intensive care unit followed by two to three days on a hospital ward. Light daily activities can usually resume after two weeks, while strenuous exercise should be avoided for four to six weeks. Patients must take prescribed dual antiplatelet therapy consistently for at least three to six months.
The procedure itself is performed under general anaesthesia or heavy sedation, meaning you feel no pain during catheterisation. Afterward, mild soreness or bruising at the groin or wrist access site and a temporary headache are common. These symptoms are typically well managed with mild analgesics and resolve within several days under clinical supervision.
The metallic stent permanently scaffolds the arterial wall. However, long-term success requires preventing in-stent restenosis (cellular tissue re-growth inside the stent) and recurrent atherosclerosis. Strict adherence to prescribed dual antiplatelet medication, cholesterol management with statins, blood pressure regulation and smoking cessation are essential to keep the stented artery patent over your lifetime.
Primary risks include periprocedural ischemic stroke from dislodged emboli, intracranial haemorrhage from vessel rupture or hyperperfusion, arterial dissection, in-stent restenosis, access-site hematoma and contrast-related reactions. Guidelines from major stroke organisations advise that stenting should only be performed in high-volume neurointerventional centres when medical therapy has proved insufficient to prevent recurrent symptoms.
For initial management, medical therapy with dual antiplatelet drugs and aggressive risk-factor control is preferred because it avoids acute procedural hazards. Intracranial stenting is considered only when severe stenosis (greater than 70%) causes recurrent strokes or transient ischemic attacks despite optimal medical therapy. A specialist team will determine whether the potential benefits outweigh procedural risks.
Most patients require a stay of seven to ten days in Turkey. This duration allows for pre-procedural imaging and consultations, three to five days of inpatient hospital care including neuro-intensive monitoring, post-operative neurological evaluation and blood pressure stabilization before receiving clinical fitness-to-fly clearance for the journey home.
Patient stories